A detailed history of Castleview Partners, LLC transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Castleview Partners, LLC holds 29,900 shares of PROK stock, worth $49,634. This represents 0.03% of its overall portfolio holdings.

Number of Shares
29,900
Previous 32,921 9.18%
Holding current value
$49,634
Previous $55,000 9.09%
% of portfolio
0.03%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025

SELL
$1.46 - $2.15 $4,410 - $6,495
-3,021 Reduced 9.18%
29,900 $50,000
Q3 2024

Oct 21, 2024

BUY
$1.8 - $2.5 $59,257 - $82,302
32,921 New
32,921 $63,000

Others Institutions Holding PROK

About PROKIDNEY CORP ORD SHS CL A(CY


  • Ticker PROK
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,540,200
  • Market Cap $102M
More about PROK
Track This Portfolio

Track Castleview Partners, LLC Portfolio

Follow Castleview Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleview Partners, LLC with notifications on news.